BRIM Biotechnology Inc has a strong liquidity position, with a current ratio of 53.17, indicating that its current assets significantly exceed its current liabilities. The company holds substantial…
The company's capital structure is characterized by a debt-to-equity ratio of 1.36, indicating a moderate reliance on debt financing. Its liquidity position is assessed as medium, with a current ra…
The company maintains a strong liquidity position, with a current ratio of 1.29 and cash and equivalents amounting to 1,428,867,000 JPY. This liquidity is supported by a low debt-to-equity ratio of…
ANGEN.IS has a market capitalization of 2.44 billion TRY and a price-to-book ratio of 1.41, indicating that the market values the company at a moderate premium to its book value. The company's liqu…
Atea Pharmaceuticals Inc has a capital structure characterized by a debt-to-equity ratio of 0.0, indicating no long-term debt obligations. The company maintains a strong liquidity position with a c…
Bullfrog AI has a strong liquidity position, with $2.18 million in cash and equivalents and no long-term debt, resulting in a debt-to-equity ratio of 0.0. The company's current ratio of 3.85 indica…
BLO.CD maintains a strong liquidity position with a current ratio of 6.2, indicating the company can easily cover its short-term liabilities with its current assets. The company holds $2.3 million…
BLTE.O maintains a strong liquidity position, with a current ratio of 50.02, indicating that its current assets significantly exceed its current liabilities. The company has no long-term debt and a…
Bonus Biogroup maintains a strong liquidity position with cash and equivalents of ILS 20.45 million, which significantly exceeds its total liabilities of ILS 16.88 million, resulting in a current r…
Fermenta Biotech Ltd exhibits a capital structure with a debt-to-equity ratio of 0.48, indicating a relatively balanced mix of debt and equity financing. The company's liquidity position is charact…
Fortis Malar Hospitals Ltd exhibits a strong capital structure, with a debt-to-equity ratio of 0.0, indicating no long-term debt obligations. The company maintains a high liquidity position, with a…
IMHM.BK's capital structure is characterized by a high debt-to-equity ratio of 1.99, indicating a significant reliance on debt financing. The company's liquidity position is assessed as medium, wit…
JMI Hospital Requisite Manufacturing Ltd maintains a strong liquidity position, with a current ratio of 3.08, indicating the company can cover its short-term liabilities more than three times over.…
KMC Speciality Hospitals maintains a debt-to-equity ratio of 0.57, indicating a moderate reliance on debt financing relative to equity. The company's liquidity position is assessed as medium, with…
Lobe Technology Inc. has a current liquidity position that is characterized by a current ratio of 3.13, indicating that the company has sufficient current assets to cover its current liabilities. H…
MEM.AX has a market price of 0.005 AUD and a market capitalization of 14,236,168.71 AUD, indicating a small-cap profile. The company's price-to-book ratio is 3.28, and its price-to-tangible-book ra…
Modular Medical Inc has a strong liquidity position, with a current ratio of 6.66, indicating that it holds significantly more current assets than current liabilities. The company's cash and equiva…
MVMD.CD has a strong liquidity position, as evidenced by a current ratio of 9.26, indicating that the company has significantly more current assets than current liabilities. The company holds CAD 1…
Optiscan Imaging Ltd has a fully diluted share count of 1,044,176,632 shares, with no difference between basic and diluted shares outstanding, indicating no dilution risk from stock options or conv…
Precipio Inc has a market capitalization of $51.05 million and a price-to-book ratio of 4.0, indicating a premium valuation relative to its book value. The company's liquidity position is weak, wit…
PVCT.PK exhibits a highly leveraged capital structure, with total liabilities of $6,996,240 and total equity of -$6,298,740, resulting in a negative debt-to-equity ratio of -0.45. The company's liq…
RGEN.BO maintains a debt-to-equity ratio of 0.86, indicating a moderate reliance on debt financing relative to equity. The company's liquidity position is assessed as medium, with only INR 375,000…
RTGN.PK exhibits a highly leveraged capital structure, with total liabilities of $23.24 million and total equity of -$2.30 million, resulting in a debt-to-equity ratio of -0.02. The company's liqui…
SHL Telemedicine has a fully diluted share count of 37,058,574 shares, with no difference between basic and diluted shares, indicating no dilution risk from stock options or convertible securities.…
SMOL.BO maintains a conservative capital structure with a debt-to-equity ratio of 0.24, indicating a relatively low reliance on debt financing. The company's liquidity position is characterized as…
SS Innovations International Inc operates with a market capitalization of $778.9 million and a price-to-book ratio of 20.38, indicating a premium valuation relative to its book value. The company's…
TIDT.BO has a debt-to-equity ratio of 0.84, indicating a moderate level of leverage, and a current ratio of 1.69, suggesting it has sufficient short-term assets to cover its short-term liabilities.…
United-Guardian Inc maintains a strong liquidity position, with a current ratio of 7.31, indicating a robust ability to meet short-term obligations. The company's liquidity_fpt score is high, suppo…
The company's capital structure is characterized by a debt-to-equity ratio of 0.53, indicating a moderate reliance on debt financing. Its liquidity position is assessed as medium, with a current ra…
Hubei Guangji Pharmaceutical Co Ltd has a debt-to-equity ratio of 1.29, indicating a moderate reliance on debt financing, and a current ratio of 1.01, suggesting limited short-term liquidity cushio…
The company maintains a relatively balanced capital structure, with a debt-to-equity ratio of 0.44, indicating a moderate reliance on debt financing. Its liquidity position is characterized as medi…
Infund Holding Co Ltd maintains a capital structure with a debt-to-equity ratio of 0.28, indicating a relatively conservative leverage position. The company's liquidity is assessed as medium, with…
The company's capital structure shows a low debt-to-equity ratio of 0.04, indicating a conservative leverage position. However, the liquidity risk is rated as medium, and the company has negative n…
Tibet Aim Pharm Inc has a liquidity position that is relatively strong, with a current ratio of 2.7, indicating that the company has 2.7 times more current assets than current liabilities. However,…
Guiyang Xintian Pharmaceutical Co Ltd maintains a debt-to-equity ratio of 0.69, indicating a moderate level of leverage relative to its equity base. The company's liquidity is assessed as medium, w…
Wuhan Easy Diagnosis Biomedicine Co Ltd maintains a strong liquidity position, with a current ratio of 3.26, indicating that it holds more than three times as much in current assets as it does in c…
Hyundai Pharmaceutical Co Ltd maintains a debt-to-equity ratio of 0.51, indicating a moderate reliance on debt financing relative to equity. The company's liquidity position is characterized as med…
ChoA Pharmaceutical has a debt-to-equity ratio of 0.57, indicating a moderate reliance on debt financing, and a current ratio of 1.41, suggesting it has sufficient short-term assets to cover its li…
HLB Pharmaceutical Co Ltd maintains a relatively strong capital structure, with a debt-to-equity ratio of 0.17, indicating a low reliance on debt financing. The company's liquidity position is char…
The company maintains a debt-to-equity ratio of 0.71, indicating a moderate level of leverage relative to its equity base. Its current ratio of 1.55 suggests that it has sufficient short-term asset…
The company's capital structure is characterized by a debt-to-equity ratio of 0.54, indicating a moderate reliance on debt financing. Its liquidity position is assessed as medium, with a current ra…
Amicogen Inc operates with a capital structure that shows a debt-to-equity ratio of 1.03, indicating a relatively balanced mix of debt and equity financing. The company's liquidity position is char…
Kolon Life Science Inc maintains a relatively strong capital structure with a debt-to-equity ratio of 0.18, indicating a low reliance on debt financing. The company's liquidity position is assessed…
Qurient's capital structure is characterized by a relatively high level of liquidity, with a current ratio of 13.23, indicating strong short-term financial health. The company holds significant cas…
The company has a strong liquidity position, with cash and equivalents amounting to ¥18,252,130,000, which significantly exceeds its total liabilities of ¥101,036,000, resulting in a current ratio…
New Century Healthcare Holding Co Ltd has a basic and diluted share count of 490,025,000 shares, indicating no immediate dilution pressure from share issuance. However, the liquidity risk remains u…
The company's capital structure is characterized by a debt-to-equity ratio of 0.45, indicating a relatively conservative leverage position. However, the company's liquidity is assessed as medium, w…
The company's capital structure is characterized by a debt-to-equity ratio of 0.72, indicating a moderate reliance on debt financing. However, its liquidity position is weak, with a current ratio o…
Woojung Bio Inc operates with a capital structure that is heavily leveraged, with a debt-to-equity ratio of 2.71, indicating a high reliance on debt financing. The company's liquidity position is c…
The company's capital structure is characterized by a relatively low debt-to-equity ratio of 0.17, indicating a conservative leverage position compared to industry norms. However, the company's liq…
Concord Healthcare Group Co Ltd exhibits a capital structure with a debt-to-equity ratio of 1.69, indicating a significant reliance on debt financing. The company's liquidity position is characteri…
The company's capital structure is characterized by a high debt-to-equity ratio of 0.75, indicating a moderate reliance on debt financing. The liquidity position is assessed as medium, with a curre…
Aptamer Sciences Inc has a market capitalization of KRW 47.62 billion and a price-to-book ratio of 3.67, indicating a premium valuation relative to its book value. The company's liquidity position…
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Ltd maintains a strong liquidity position, with a current ratio of 11.17, indicating that the company has significantly more current ass…
The company's capital structure is heavily leveraged, with a debt-to-equity ratio of 1.45, indicating a significant reliance on debt financing. Its liquidity position is weak, as evidenced by a cur…
The company's capital structure is highly leveraged, with a debt-to-equity ratio of 3.86, indicating a significant reliance on debt financing. Despite holding 13.25 billion KRW in cash and equivale…
The company's capital structure is characterized by a debt-to-equity ratio of 1.64, indicating a relatively high reliance on debt financing. Its liquidity position is assessed as medium, with a cur…
Dynamic Medical Technologies Inc maintains a conservative capital structure with a debt-to-equity ratio of 0.35, indicating a low reliance on debt financing. The company holds substantial liquidity…
Seikagaku Corp maintains a strong liquidity position, with a current ratio of 5.02 and cash and equivalents amounting to ¥15.13 billion, which is significantly higher than the typical liquidity nee…
Avita Corp's capital structure is characterized by a market price of $31.00 per share and a market capitalization of $1.19 billion, with a price-to-book ratio of 1.35 and a price-to-tangible-book r…
Cowealth Medical's capital structure shows a debt-to-equity ratio of 0.33, indicating a relatively conservative leverage position compared to industry norms. The company's liquidity is assessed as…
The company's capital structure is characterized by a debt-to-equity ratio of 0.29, indicating a relatively low level of leverage. The liquidity position is marked by a current ratio of 2.66, sugge…
Rznomics Inc exhibits a highly leveraged capital structure, with a price-to-book ratio of 34.53 and a price-to-tangible-book ratio of 34.53, indicating a significant premium over its book value. Th…
Tsubota Laboratory Inc maintains a strong liquidity position, with cash and equivalents amounting to ¥1,538,853,000, representing 61.5% of total assets. The company's liquidity FPT (free cash flow…
The company maintains a strong liquidity position, with cash and equivalents amounting to ¥2.3 billion, representing 79.9% of total assets. The current ratio of 6.28 indicates a robust ability to c…
Guizhou Yibai Pharmaceutical Co Ltd has a debt-to-equity ratio of 0.34, indicating a relatively conservative capital structure. However, the company reported negative net income of CNY -329.6 milli…
The company maintains a relatively strong liquidity position, with a current ratio of 3.01, indicating that it has sufficient current assets to cover its current liabilities. However, its net cash…
The company's capital structure is heavily leveraged, with a debt-to-equity ratio of 2.62, indicating a significant reliance on debt financing. Despite a current ratio of 0.49, which suggests limit…
The company's capital structure is highly leveraged, with total liabilities of TWD 141.65 billion and total equity of TWD -126.79 billion, resulting in a negative debt-to-equity ratio of -0.03. Liq…
The company maintains a conservative capital structure with a debt-to-equity ratio of 0.1, indicating a low reliance on debt financing. Its liquidity position is characterized as medium, with a cur…
Agimexpharm's capital structure is heavily leveraged, with a debt-to-equity ratio of 1.36, indicating a significant reliance on long-term debt to finance operations. The company's liquidity positio…
Bafna Pharmaceuticals Ltd has a liquidity position that is in line with the industry median, with a current ratio of 1.63 and a debt-to-equity ratio of 0.33. However, the company has negative net c…
Baumer SA maintains a conservative capital structure with a debt-to-equity ratio of 0.13, indicating a low reliance on debt financing. The company's liquidity position is characterized as medium ri…
BIOE.PK has a negative total equity of -$2.07 billion, indicating a significant deficit in its capital structure, and a debt-to-equity ratio of -0.03, which suggests that the company is not leverag…
Bharat Biotech maintains a strong liquidity position, with a current ratio of 3.56, indicating the company can cover its short-term liabilities more than three times over. However, the company has…
CHIM.BO maintains a strong liquidity position, with a current ratio of 4.61, indicating the company can easily cover its short-term liabilities with its current assets. The company holds INR 99.9 m…
Cosmo Steel maintains a relatively strong liquidity position, with a current ratio of 2.98, indicating that it holds nearly three times as much in current assets as it does in current liabilities.…
DP1.HNO has a debt-to-equity ratio of 1.04, indicating a relatively balanced capital structure with a moderate reliance on debt financing. The company's liquidity position is assessed as medium, wi…
The company maintains a strong liquidity position, with a current ratio of 2.69, indicating that it has more than double the current assets to cover its short-term liabilities. However, its net cas…
EQ Inc's capital structure is highly leveraged, with total liabilities of CAD 4.53 billion and total equity of CAD -1.46 billion, resulting in a negative debt-to-equity ratio of -0.52. Despite a ne…
Everest Organics Ltd has a debt-to-equity ratio of 1.26, indicating a moderate reliance on debt financing, while its current ratio of 0.94 suggests limited short-term liquidity. The company's opera…
Exact Therapeutics AS has a liquidity position characterized by a current ratio of 1.65, indicating that the company has sufficient current assets to cover its current liabilities. The company's ca…
FISC.NS has a debt-to-equity ratio of 0.25, indicating a relatively conservative capital structure with limited leverage. The company's liquidity position is assessed as medium, with a current rati…
The company's capital structure is characterized by a debt-to-equity ratio of 0.31, indicating a relatively conservative leverage position. However, the liquidity risk is assessed as medium, with a…
GUJK.NS has a total equity of INR 259.36 million and a total liabilities of INR 294.09 million, resulting in a debt-to-equity ratio of 0.32, which is relatively low and suggests a conservative capi…
LPH.BK maintains a conservative capital structure with a debt-to-equity ratio of 0.19, indicating a relatively low reliance on debt financing. The company's liquidity position is characterized as m…
Check Cap Ltd has a market price of $1.79 and a market cap of $12,566,698.58, indicating a relatively small market capitalization. The company's financial snapshot shows that the number of shares o…
The company's capital structure is characterized by a debt-to-equity ratio of 1.72, indicating a relatively high level of leverage. Its liquidity position is assessed as medium, with a current rati…
MediNavi AG has a basic and diluted share count of 2,443,463 shares, indicating no immediate dilution pressure from share issuance. However, the company's liquidity risk remains unassessed due to t…
Medico Remedies Ltd maintains a conservative capital structure, with a debt-to-equity ratio of 0.15, indicating a relatively low reliance on debt financing. The company's liquidity position is char…
Orogen Royalties Inc maintains a relatively strong liquidity position, with CAD 7,912,000 in cash and equivalents, which provides a buffer against short-term obligations. The company's total liabil…
Pharmedic maintains a strong capital structure with no long-term debt and a debt-to-equity ratio of 0.0, indicating a fully equity-funded balance sheet. The company's liquidity position is reflecte…
PPHM.BO's capital structure is characterized by a debt-to-equity ratio of 0.66, indicating a moderate level of leverage. The company's liquidity position is assessed as medium, with a current ratio…
Raphael Pharmaceutical Inc has a negative equity position of -$103,000,000, indicating a significant deficit in its capital structure. The company holds $287,000,000 in cash and equivalents, which…
SEI Medical PCL's capital structure and liquidity position is partially obscured due to the absence of balance-sheet inputs and no going-concern language in the source documents, preventing a full…
Shilpa Medicare Ltd maintains a conservative capital structure with a debt-to-equity ratio of 0.25, indicating a relatively low reliance on debt financing. The company's liquidity position is asses…
LIR Life Sciences Corp has a highly liquid capital structure, as evidenced by a current ratio of 38.11, indicating that its current assets significantly exceed its current liabilities. The company…
SLP.BK maintains a strong liquidity position, with a current ratio of 7.53, indicating the company can easily cover its short-term liabilities with its current assets. The company's cash and equiva…
SoftOx Solutions AS has a liquidity position that appears to be strong, with a current ratio of 1.8, indicating that the company has 1.8 NOK in current assets for every 1 NOK in current liabilities…
The company maintains a conservative capital structure with a debt-to-equity ratio of 0.04, indicating minimal leverage relative to its equity base of $3.46 million. Total liabilities stand at $1.9…
SYG.WA has a market capitalization of $15.15 million and a price-to-earnings ratio of 5.92, indicating a relatively low valuation compared to its earnings. The company's price-to-book ratio is 0.48…
Vikram Thermo maintains a strong liquidity position, with a current ratio of 3.13, indicating that it holds more than three times as much in current assets as it does in current liabilities. Howeve…
Zentek operates with a capital structure that includes total liabilities of CAD 3.65 million and total equity of CAD 14.75 million, resulting in a low debt-to-equity ratio of 0.05. The company's li…
Jinghua Pharmaceutical Group Co Ltd maintains a strong liquidity position, with a current ratio of 5.13, indicating that it has more than five times the current assets to cover its current liabilit…
Bukwang Pharm's capital structure is characterized by a strong liquidity position, with cash and equivalents amounting to KRW 109.2 billion, representing 31.3% of total assets. The company's liquid…
The company's capital structure is characterized by a debt-to-equity ratio of 0.57, indicating a moderate reliance on debt financing relative to equity. Liquidity is assessed as medium, with a curr…
The company maintains a strong liquidity position, with a current ratio of 5.25, indicating that it has more than five times the current assets to cover its current liabilities. Its cash and equiva…
iNtRON Biotechnology Inc maintains a strong liquidity position, with cash and equivalents amounting to KRW 44,280,001,021, representing 45.1% of total assets. The company's liquidity FPT (free cash…
The company maintains a capital structure with a debt-to-equity ratio of 0.98, indicating a relatively balanced mix of debt and equity financing. Its liquidity position is assessed as medium, with…
The company's capital structure is characterized by a debt-to-equity ratio of 0.51, indicating a moderate reliance on debt financing. Its liquidity position is assessed as medium, with a current ra…
High Tech Pharm Co Ltd maintains a strong liquidity position, with a current ratio of 2.16, indicating the company can cover its short-term liabilities with its short-term assets. However, the comp…
The company's capital structure is characterized by a market capitalization of 911.36 million CNY and a price-to-book ratio of 1.53, indicating a moderate premium over its book value. The company's…
Shanghai INT Medical Instruments Co Ltd maintains a conservative capital structure, with a debt-to-equity ratio of 0.36, indicating a relatively low reliance on debt financing. The company's liquid…
The company maintains a strong liquidity position, with a current ratio of 3.87, indicating that it has sufficient short-term assets to cover its short-term liabilities. Its liquidity FPT (free cas…
Hi-Clearance Inc maintains a conservative capital structure with a debt-to-equity ratio of 0.34, well below the industry median of 0.65, indicating a strong equity position relative to its liabilit…
The company's capital structure is characterized by a debt-to-equity ratio of 1.15, indicating a moderate reliance on debt financing. Its liquidity position is assessed as medium, with a current ra…
The company maintains a strong liquidity position, with cash and equivalents amounting to KRW 2,866,338,310, which is significantly higher than its total liabilities of KRW 5,470,415,350. The liqui…
Hebei Changshan Biochemical Pharmaceutical Co Ltd has a debt-to-equity ratio of 2.16, indicating a capital structure that is heavily leveraged, with total liabilities of CNY 3.15 billion and total…
Hunan Er-Kang Pharmaceutical Co Ltd has a debt-to-equity ratio of 0.15, indicating a relatively conservative capital structure with limited leverage. The company's liquidity position is assessed as…
Ningbo David Medical Device Co Ltd maintains a strong liquidity position, with a current ratio of 3.71, indicating the company can cover its short-term liabilities more than three times over. The c…
Guangdong VTR Bio-Tech Co Ltd has a strong liquidity position, with a current ratio of 3.97, indicating that it holds nearly four times more current assets than current liabilities. However, the co…
Sichuan Goldstone Asia Pharmaceutical Inc maintains a strong liquidity position with a current ratio of 2.18, indicating the company can cover its short-term liabilities more than twice over. Howev…
Withus Pharmaceutical Co Ltd maintains a conservative capital structure, with a debt-to-equity ratio of 0.21, indicating a relatively low reliance on debt financing. The company's liquidity positio…
Cenra Inc maintains a relatively conservative capital structure, with a debt-to-equity ratio of 0.39, indicating a moderate reliance on debt financing. The company's liquidity position is character…
The company maintains a strong liquidity position, with a current ratio of 2.01 and cash and equivalents of TWD 443.9 million, which supports its short-term obligations. Its price-to-book ratio of…
The company's capital structure is characterized by a lack of detailed liquidity metrics, as liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern lan…
The company maintains a conservative capital structure, with a debt-to-equity ratio of 0.18, indicating a low reliance on debt financing. Its liquidity position is characterized by a current ratio…
The company's capital structure is characterized by a debt-to-equity ratio of 0.55, indicating a moderate reliance on debt financing. However, its liquidity position is weak, with a negative free c…
Intech Biopharm Ltd has a market price of 15.75 TWD, resulting in a market capitalization of 2,809,878,750 TWD. The company's price-to-book ratio is 2.57, and its price-to-tangible-book ratio is al…
The company's capital structure is characterized by a high proportion of equity, with total equity of TWD 157,838,000 and total liabilities of TWD 26,097,000, resulting in a debt-to-equity ratio of…
Enimmune Corp operates with a capital structure that includes a basic and diluted share count of 72.134 million shares, with no significant difference between the two, indicating no immediate dilut…
6661.TWO has a market capitalization of TWD 410.15 million and a price-to-earnings ratio of 308.38, indicating a high valuation relative to its earnings. The company's liquidity position is charact…
Alar Pharmaceuticals Inc maintains a strong liquidity position with a current ratio of 35.07, indicating a significant buffer of current assets relative to current liabilities. The company's cash a…
A Plus Biotechnology Co Ltd maintains a strong liquidity position, as evidenced by a current ratio of 5.71, indicating that the company has more than five times the current assets to cover its curr…
Amvis Holdings Inc maintains a capital structure with a debt-to-equity ratio of 1.11, indicating a moderate reliance on debt financing. The company's liquidity position is characterized by a curren…
The company's capital structure is characterized by a market price of 13.0 and a market cap of 462,189,000.0, with a price-to-book ratio of 9.07 and a price-to-tangible-book ratio of 9.07, indicati…
The company maintains a strong liquidity position, with a current ratio of 19.93, indicating a high ability to meet short-term obligations. However, the company reported negative operating and net…
The company's capital structure is characterized by a high proportion of equity, with total equity of 850,658,000 TWD and total liabilities of 57,459,000 TWD, resulting in a debt-to-equity ratio of…
The company maintains a strong liquidity position, with cash and equivalents amounting to TWD 407.15 million, representing 36.5% of total assets. The debt-to-equity ratio of 0.07 indicates a conser…
The company maintains a strong liquidity position, with cash and equivalents amounting to $23.03 million, representing 48.4% of total assets. The current ratio of 3.97 indicates a robust ability to…
The company maintains a strong liquidity position, with a current ratio of 5.5, indicating a robust ability to meet short-term obligations. Its liquidity is further supported by cash and equivalent…
The company's capital structure shows a debt-to-equity ratio of 0.53, indicating a moderate reliance on debt financing. However, its liquidity position is constrained, with a current ratio of 1.03,…
Areeya Property PCL has a liquidity risk score of medium, with a debt-to-equity ratio of 3.23, indicating a high reliance on debt financing. The company's cash and equivalents amount to 28.31 milli…
ABVC Biopharma Inc has a market capitalization of $27.48 million and a price-to-book ratio of 3.53, indicating that the market is valuing the company's equity at a premium relative to its book valu…
Advent Pharma maintains a conservative capital structure with a debt-to-equity ratio of 0.05, significantly below the industry median, indicating a low reliance on debt financing. The company's liq…
The company exhibits a severely distressed capital structure, characterized by negative total equity of -17,331,490 CAD and total liabilities of 19,304,910 CAD against total assets of 1,973,420 CAD…
The company's capital structure is characterized by a debt-to-equity ratio of 0.54, indicating a moderate level of leverage. However, its liquidity position is rated as medium, with a current ratio…
Bijoy Hans Ltd exhibits a strong liquidity position, with a current ratio of 18.42, indicating that the company holds significantly more current assets than current liabilities. The company's cash…
The company's capital structure is highly leveraged, with total liabilities of $4.95 billion and total equity of -$4.54 billion, resulting in a negative debt-to-equity ratio of -0.49. Liquidity is…
Vi sender deg én e-post når Handelsavisen lanseres. Ingen spam, ingen annen bruk.
Ved å registrere deg samtykker du til å motta ett enkelt varsel fra Handelsavisen på lanseringsdagen.